missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Pou6f2 Polyclonal Antibody

Description
This antibody is predicted to react with bovine, human and rat based on sequence homology. This antibody is tested in Peptide ELISA: antibody detection limit dilution 16,000.
This gene encodes a member of the POU protein family characterized by the presence of a bipartite DNA binding domain, consisting of a POU-specific domain and a homeodomain, separated by a variable polylinker. The DNA binding domain may bind to DNA as monomers or as homo- and/or heterodimers, in a sequence-specific manner. The POU family members are transcriptional regulators, many of which are known to control cell type-specific differentiation pathways. This gene is a tumor suppressor involved in Wilms tumor (WT) predisposition. Alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.
Specifications
Specifications
| Antigen | Pou6f2 |
| Applications | Western Blot |
| Classification | Polyclonal |
| Concentration | 0.5 mg/mL |
| Conjugate | Unconjugated |
| Formulation | TBS with 0.5% BSA and 0.02% sodium azide; pH 7.3 |
| Gene | Pou6f2 |
| Gene Accession No. | Q8BJI4 |
| Gene Alias | D130006K24Rik; POU class 6 homeobox 2; POU domain class 6 transcription factor 2; POU domain, class 6, transcription factor 2; Pou6f2; Retina-derived POU domain factor 1; retina-derived POU-domain factor-1; RPF1; RPF-1; Wilms tumor suppressor locus; WT5; WTSL |
| Gene Symbols | Pou6f2 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?